Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New pain pump after back surgery could cut opioid use

NCT ID NCT00825422

Symptom relief Sponsor: University Hospital, Bordeaux Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a continuous drip of numbing medicine into the surgical wound for two days after back fusion surgery could reduce pain and speed recovery better than a placebo. Fifty adults having lumbar fusion for degenerative spine disease took part. The goal was to improve pain control, reduce opioid side effects, and help patients get back on their feet faster.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

50 people

The number who actually took part.

Start date

Jan 2009

Finished

Aug 2010

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Necessity to use safety contraceptive methods for women who can procreate * Patients with American Society of Anesthesiologists physical status I, II or III * Patients scheduled to undergo a posterior lumbar arthrodesis on one at three levels treated, * Posterior lumbar arthrodesis is only executed on lumbar degenerative spine, * A written informed consent has to sign by the patient and the investigator before beginning clinical study * Patients affiliated with social security system Exclusion Criteria: * Pregnancy and breast-feeding * Posterior lumbar arthrodesis exceeding three levels treated, * Posterior lumbar arthrodesis post-traumatic or with neoplastic disorders or with the aim of correcting cord compression, * Epilepsy not controlled through medication, * Preoperative cognitive dysfunction or psychiatric disorders, * Cardiac or breathing dysfunctions, * Preoperative opioid consumption, * Patients who have a known local anesthetic, or morphine or/and acetaminophen allergy, * Lack of understanding about the study or inability to use the patient controlled analgesic device, * Patients protected by the law, guardianship, * Patients who take a share in an another clinical study in the same time,

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Degenerative lumbar spine disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Hyperalgesia lumbar disk degenerative disorder Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hyperalgesia

Contacts and locations

Locations

  • University Hospital

    Bordeaux, 33076, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.